Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 1475 entries
View as:

A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00351325 Org: User:
Start: 09/30/07 End: 03/31/09 Due: 03/31/10

Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04269356 Org: User:
Start: 02/18/20 End: 03/30/21 Due: 03/30/22

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01709162 Org: User:
Start: 03/31/13 End: 07/31/14 Due: 07/31/15

A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02982954 Org: User:
Start: 01/16/17 End: 10/06/21 Due: 10/06/22

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05932303 Org: User:
Start: 07/12/23 End: 10/23/23 Due: 10/23/24

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01120457 Org: User:
Start: 08/31/10 End: 11/30/14 Due: 11/30/15

Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020

Phase: N/A Priority: Normal
NCT ID: NCT02068053 Org: User:
Start: 03/31/14 End: 04/30/14 Due: 04/30/15

A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05932277 Org: User:
Start: 06/29/23 End: 09/13/23 Due: 09/13/24

Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01092325 Org: User:
Start: 06/30/09 End: 05/31/10 Due: 05/31/11

A Study of Abatacept in Patients With Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00410410 Org: User:
Start: 12/31/06 End: 11/30/09 Due: 11/30/10

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01393964 Org: User:
Start: 01/06/12 End: 07/18/16 Due: 07/18/17

Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)

Phase: N/A Priority: Normal
NCT ID: NCT00352560 Org: User:
Start: 07/31/06 End: 06/30/07 Due: 06/30/08

Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT01691794 Org: User:
Start: 11/30/12 End: 02/20/17 Due: 02/20/18

Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00884546 Org: User:
Start: 07/31/09 End: 03/31/12 Due: 03/31/13

Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries

Phase: N/A Priority: Normal
NCT ID: NCT02632890 Org: User:
Start: 11/29/16 End: 04/28/17 Due: 04/28/18

A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03698513 Org: User:
Start: 10/04/18 End: 02/19/19 Due: 02/19/20

A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00240370 Org: User:
Start: 10/31/03 End: - Due: -

Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02990611 Org: User:
Start: 12/06/16 End: 08/31/25 Due: 08/31/26

A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT04089839 Org: User:
Start: 04/21/16 End: 01/16/20 Due: 01/16/21

Predictors of Adherence to Orencia

Phase: N/A Priority: Normal
NCT ID: NCT01136707 Org: User:
Start: 12/31/09 End: 07/31/10 Due: 07/31/11

Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)

Phase: N/A Priority: Normal
NCT ID: NCT02175966 Org: User:
Start: 07/28/14 End: 12/17/15 Due: 12/17/16

Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01227668 Org: User:
Start: 03/31/11 End: 06/30/12 Due: 06/30/13

A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00546715 Org: User:
Start: 11/30/07 End: 05/31/08 Due: 05/31/09

A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT03254784 Org: User:
Start: 09/13/17 End: 11/15/17 Due: 11/15/18

Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab

Phase: N/A Priority: Normal
NCT ID: NCT05170685 Org: User:
Start: - End: - Due: -